Evidence map›Paper›PMID 34287566›Full record

ReviewEinstein (Sao Paulo, Brazil)2021

MicroRNAs: understanding their role in gene expression and cancer.

Ariany Lima Jorge, Erik Ribeiro Pereira, Christian Sousa de Oliveira, Eduardo Dos Santos Ferreira, Edmara Toledo Ninzoli Menon, Susana Nogueira Diniz, Julia Alejandra Pezuk

Open access · diamondAbstract readReview
In one paragraph

Review in Einstein (Sao Paulo, Brazil), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ariany Lima JorgeUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-7119-3151
Erik Ribeiro PereiraUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-9404-0606
Christian Sousa de OliveiraUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-4556-3598
Eduardo Dos Santos FerreiraUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-4975-8472
Edmara Toledo Ninzoli MenonUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-9142-7637
Susana Nogueira DinizUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-4329-848X
Julia Alejandra PezukUniversidade Anhanguera de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-5412-6619
Anhanguera (Brazil) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are small RNA molecules that regulate gene expression in cells. These small molecules comprise 17 to 25 nucleotides and are able to recognize target messenger RNAs by sequence complementarity and regulate their protein translation. Different microRNAs are expressed in all human cells. There is over 2,500 microRNAs described in humans that are involved in virtually all biological processes. Given their role as gene expression regulators, these molecules have been widely investigated and are thought to be associated with some specific physiological and pathological conditions, being proposed as biomarkers. It has recently been reported that microRNAs are secreted outside cells and are involved in intercellular communication. MicroRNAs in biological fluids are named circulating and have been detected in all body fluids, although the expression profile is specific for each type. The major advantages of using circulating microRNAs as biological markers are the high stability of those molecules and the wide availability of samples. Also, given the individual nature of microRNA expression changes, these molecules have a high potential for use in personalized medicine. In fact, microRNA expression profile determination may support disease recognition and diagnosis, and can be used to monitor therapeutic responses and establish patient prognosis, assisting in choice of treatment. This review provides a general overview of microRNAs and discusses the importance of those molecules in cancer, for deeper understanding of their role in this disease.

Indexed as

MicroRNAsNeoplasmsBiomarkersGene ExpressionHumansPrognosisBiomarkersMicroRNAs

Identifiers

PMID34287566
PMCPMC8277234
OpenAlexW3182630913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.